Clinical Trial Update: Novel Treatment of Radiation Associated Dysphagia With Statins [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating statins as a treatment for radiation-associated dysphagia in patients with head and neck cancer and is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Radiation-associated Dysphagia

Drugs mentioned

• Statins (class) (HMG-CoA reductase inhibitor)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Radiation-associated Dysphagia, Head &Amp; Neck Cancer | Phase 2 | Status: RECRUITING